Clin Cancer Res 20(21):5527-36, 2014
In the cross-sectional serum proteomics study by Zhang et al, higher serum levels of SERPING1 provided excellent sensitivity and specificity, distinguishing type 1 diabetic individuals and matched control individuals [4]
D&D Pharmatech CEO Lee Seul-ki added that the FDA's approval for the phase 2 trial of NLY01 in MS reflects the notable disease-modifying effects we observed in younger patients during our phase 2 Parkinson's trial, which was built on years of preclinical collaboration with Johns Hopkins University School of Medicine
Combined Influence of ABCB1 Genetic Polymorphism and DNA Methylation on Aspirin Resistance in Chinese Ischemic Stroke Patients
( g ) LC-MS/MS chromatogram showing the detection of FAD in a control Huh7.5 mock-infected sample (light blue), intracellular RNA from HCV infected Huh7.5 cells (dark blue) and in HCV particles concentrated from supernatant (yellow)
Shi R, Jin Y, Zhao S, Yuan H, Shi J, Zhao H